Quetiapine
Mostrando 1-12 de 17 artigos, teses e dissertações.
-
1. Clozapine prescription trends in Brazil in the last decade
Objective: Clozapine is a second-generation antipsychotic indicated for treatment-resistant schizophrenia. Studies in several countries have shown a low rate of clozapine use despite the fact that approximately 30% of schizophrenia cases are treatment-resistant. In Brazil, few studies have addressed the frequency and variety of antipsychotic use in individua
Brazilian Journal of Psychiatry. Publicado em: 2022
-
2. Health-related quality of life in patients treated with atypical antipsychotics
Objective: To assess health-related quality of life and associated factors in patients treated with atypical antipsychotics, as well as to determine utility values using the EuroQol-5D-3L instrument. Methods: A cross-sectional study was conducted at a state-run pharmacy in the Brazilian National Health System. Individuals were included if they were using a
Braz. J. Psychiatry. Publicado em: 2020-12
-
3. Risk factors associated with drug therapy among elderly people with Alzheimer’s disease: a cross-sectional study
ABSTRACT BACKGROUND: Improving knowledge and establishing strategies and policies for better patient safety are worldwide priorities. OBJECTIVE: To evaluate drug safety among elderly people with Alzheimer’s disease (AD). DESIGN AND SETTING: Cross-sectional study among elderly people within the National AD Assistance Protocol (PCDTDA/MS) who were livi
Sao Paulo Med. J.. Publicado em: 2020-06
-
4. Metabolic dysregulation in early onset psychiatric disorder before and after exposure to antipsychotic drugs
Antipsychotic Drugs (APDs) are being widely prescribed to treat various disorders, including schizophrenia and bipolar disorder; however, abnormal glucose metabolism and weight gain have been reported with Atypical Anti-Psychotic drugs (AAPDs) that can lead to insulin-resistance and type 2 diabetes mellitus. The study was designed to assess various biochemic
Braz. J. Pharm. Sci.. Publicado em: 30/09/2019
-
5. Thrombocytopenia with quetiapine: two case reports, one with positive rechallenge
Rev. Bras. Psiquiatr.. Publicado em: 2015-12
-
6. CHARACTERIZING THE MECHANISM OF QUETIAPINE DISTRIBUTION IN LIPID-CORE NANOCAPSULES PSEUDO-PHASES USING A VALIDATED LC/UV METHOD
Quetiapine is an atypical antipsychotic used to treat schizophrenia. However, despite great interest for its chronic therapeutic use, quetiapine has some important side effects such as weight gain induction. The development of a quetiapine nanocarrier can potentially target the drug into central nervous system, resulting in a reduction of systemic side effec
Quím. Nova. Publicado em: 2015-11
-
7. Meta-analysis on the efficacy and tolerability of the augmentation of antidepressants with atypical antipsychotics in patients with major depressive disorder
We assessed the efficacy and tolerability of the augmentation of antidepressants (ATDs) with atypical antipsychotics (AAPs) to treat patients with major depressive disorder. A retrograde study to identify relevant patient data included databases of PubMed, EMBASE, Cochrane Central Register of Controlled Trials, and Database of Abstracts of Reviews of Effects
Braz J Med Biol Res. Publicado em: 13/06/2014
-
8. Formulation and evaluation of buccoadhesive quetiapine fumarate tablets
O objetivo do presente estudo foi desenvolver e avaliar os comprimidos bucoadesivos de fumarato de quetiapina (FQ), que é extensivamente metabolizada no fígado. Os comprimidos bucoadesivos de FQ foram preparados utilizando-se HPMC K4M, HPMC K15M e a combinação de carbopol e HPC como polímeros mucoadesivos pelo método de compressão direta. O desoxicola
Brazilian Journal of Pharmaceutical Sciences. Publicado em: 2012-06
-
9. Novos usos para medicações psicotrópicas conhecidas
O objetivo desta tese de doutorado foi testar psicofármacos tradicionais em aplicações diferentes das originais, tendo por base o conhecimento de seus mecanismos de ação e uma visão clínica focada no temperamento. A primeira parte da tese é constituída pelo ensaio clínico de flunarizina comparado com haloperidol no tratamento de pacientes com esqui
Publicado em: 2008
-
10. Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial
Objectives To determine the respective efficacy of quetiapine and rivastigmine for agitation in people with dementia in institutional care and to evaluate these treatments with respect to change in cognitive performance.
BMJ Publishing Group Ltd..
-
11. Quetiapine-induced hypothyroidism
-
12. Quetiapine and rivastigmine may not work for dementia
BMJ Publishing Group Ltd..